Detalhe da pesquisa
1.
Risk-reducing mastectomy for women with hereditary breast and ovarian cancer (HBOC): analytical results of data from the Japanese Organization of HBOC.
Jpn J Clin Oncol
; 52(11): 1265-1269, 2022 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35905458
2.
Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab-paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031).
Jpn J Clin Oncol
; 52(10): 1124-1133, 2022 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35750038
3.
Pathological Complete Response Patients after Neoadjuvant Chemotherapy in Breast Cancer.
Acta Med Okayama
; 76(2): 105-111, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35503437
4.
Handling of Germline Findings in Clinical Comprehensive Cancer Genomic Profiling.
Acta Med Okayama
; 76(6): 673-678, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36549769
5.
Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N·SAS-BC 01 trial and CUBC trial).
Breast Cancer Res Treat
; 186(1): 135-147, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259001
6.
Multicenter retrospective study on the use of Curebest™ 95GC Breast for estrogen receptor-positive and node-negative early breast cancer.
BMC Cancer
; 21(1): 1077, 2021 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34610807
7.
Prospective study of hair recovery after (neo)adjuvant chemotherapy with scalp cooling in Japanese breast cancer patients.
Support Care Cancer
; 29(10): 6119-6125, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33797582
8.
Risk factors of impairment of shoulder function after axillary dissection for breast cancer.
Support Care Cancer
; 29(2): 771-778, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32468131
9.
Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy.
Support Care Cancer
; 29(1): 437-443, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32388615
10.
Influence of and Risk Factors for Axillary Web Syndrome Following Surgery for Breast Cancer.
Acta Med Okayama
; 75(1): 39-44, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649612
11.
Optimizing the timing of 3.6 mg Pegfilgrastim Administration for Dose-Dense Chemotherapy in Japanese Patients with Breast Cancer.
Acta Med Okayama
; 75(3): 357-362, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34176940
12.
Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study.
Breast Cancer Res
; 22(1): 114, 2020 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33109210
13.
Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study.
Br J Cancer
; 122(12): 1747-1753, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32238920
14.
Factors affecting enrollment in randomized controlled trials conducted for patients with metastatic breast cancer.
Jpn J Clin Oncol
; 50(8): 873-881, 2020 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32463090
15.
Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients.
Int J Clin Oncol
; 24(3): 274-287, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30515674
16.
Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis.
Cancer
; 124(14): 2923-2930, 2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29723396
17.
Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
BMC Cancer
; 18(1): 576, 2018 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29783979
18.
Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational study.
Invest New Drugs
; 35(6): 791-799, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28660549
19.
Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial.
BMC Cancer
; 17(1): 773, 2017 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29149882
20.
Impact of modifiable lifestyle factors on outcomes after breast cancer diagnosis: the Setouchi Breast Cancer Cohort Study.
Jpn J Clin Oncol
; 45(6): 600-2, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25770837